Related Experiment Video
Updated: Jan 18, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Characteristics Associated With Spontaneous Helicobacter pylori Clearance After Subtotal Gastrectomy in Patients With
So Young Byun1, Hee Sung Kim2, Ji Yong Ahn1
1Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Objective:
Helicobacter pylori eradication treatment typically occurs after gastrectomy; however, the specific criteria for eradication treatment have not been reported. This study aimed to evaluate the rates and locations of spontaneous clearance, as well as the accompanying histological changes.
Methods:
Patients with H. pylori-positive status at the time of gastric cancer diagnosis and who underwent subtotal gastrectomy at a tertiary care center in Seoul (South Korea) were prospectively enrolled in this study. H. pylori infection status and histological features (presence of mononuclear cells, neutrophils, atrophy, and intestinal metaplasia) were evaluated pre- and postoperatively at different locations in the stomach.
Results:
Sixteen patients with H. pylori-positive gastric cancer underwent subtotal gastrectomy. Of these, 13 (81.3%) showed spontaneous clearance at least once during the follow-up. Half of the patients (8, 50.0%) had cleared their infections within 6 months after surgery. Histological factors, such as neutrophil and mononuclear cell counts, atrophy, and intestinal metaplasia, did not differ according to H. pylori clearance status. The spontaneous clearance rates of H. pylori were 69.2% in the cardia, 46.1% in the fundus, 38.4% in the lesser curvature of the mid-body, and 41.6% in the greater curvature of the mid-body; the differences in clearance rates were not significant (p=0.149).
Conclusions:
The rate of spontaneous H. pylori clearance was high in patients with gastric cancer who underwent subtotal gastrectomy. Postoperative H. pylori status should be re-evaluated to confirm the presence of infection prior to considering eradicating therapy.
More Related Videos
03:32Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment
Published on: December 27, 2024
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...